![Peng Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Peng Lu currently works at Pharvaris NV, as Chief Medical Officer & Head-Research & Technology from 2024.
Dr. Lu also formerly worked at Takeda Nederland BV, as Vice President.
Dr. Lu received her doctorate degree from Beijing Medical University and doctorate degree from the University of Texas at Austin Graduate School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARVARIS N.V. 0,09 % | 18/06/2026 | 65.631 ( 0,09 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARVARIS N.V. | Director Técnico/Científico/I+D | 07/02/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Takeda Nederland BV
 Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Beijing Medical University
 Beijing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Nederland BV
Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
University of Texas at Austin Graduate School
 University of Texas at Austin Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
